Journals Library


EME - 13/50/17

Treatment of Pustular Psoriasis with IL-1 receptor antagonist anakinra: a randomised, placebo-controlled trial and associated mechanistic studies.

Project title: Treatment of Pustular Psoriasis with IL-1 receptor antagonist anakinra: a randomised, placebo-controlled trial and associated mechanistic studies.

Call to action: 13/50 13/50 Skin Disorders

Research type: Primary Research

Chief investigator: Professor Catherine SmithORCID logoorcid.org/0000-0001-9918-1144

Contractor: Guy's and St Thomas' NHS Foundation Trust

Cost: £1,070,754.00

Co-investigators: Dr Francesca Capon, Dr Helen Lachmann, Dr Richard Warren, Dr Victoria Cornelius, Ms Helen McAteer, Professor Christopher Griffiths, Professor David Burden, Professor Jonathan Barker, Professor Nicholas Reynolds.

Started: November 2015 | Status: Research in progress

ISRCTN: 13127147

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.